Building on the insights from our previous seminar on licensing within the pharmaceutical industry, we delve deeper into the critical processes and vital intellectual property (IP) aspects of in-licensing, due diligence (DD) and mergers & acquisitions (M&A). Hear from experts in the field: Tomas Lundquist, Vice President, Head of IP at Sobi, Ulrika Munter, Senior...